Eli Lilly's Cardiometabolic Business Is Supporting Its Wide Moat
Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...
Pumped, dumped and chumped: "Fake news" on tariffs causes stock market whiplash
An account that goes by the handle "Walter Bloomberg" shared a snippet that reportedly came from National Economic Council ...
Eli Lilly And Novo Nordisk Could Face Policy Shifts As FDA Oversight, Tariff Risks Mount
Needham hosted an expert to discuss potential impact of trade tariffs and personnel changes on healthcare equities. Generic ...
Eli Lilly Stock Is Falling. It Isn’t Just About Tariffs.
The Trump administration did away with a Biden-era proposal to allow Medicare to start paying for weight loss drugs such as ...
Lilly Falls After Trump Drops Medicare Obesity Proposal
Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients.
Morgan Stanley sees ‘limited impact’ on Lilly from Medicare obesity news
After CMS excluded a Biden administration proposal for CMS to cover anti-obesity medications proposal from the final contract year 2026 ...
Medical Marketing & Media12h
Trump’s sweeping new tariffs inject more uncertainty into pharma industry
Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...
Mission BioCapital Announces 2024 Platinum Ticket Investments and Opening of $4 Million 2025 Platinum Program Contest
Mission BioCapital (MBC), in partnership with sponsors Eli Lilly and Company (Lilly), Ono Venture Investment (OVI), Alloy Therapeutics, and our newest sponsor, HitGen, announced today that ...